redirect to https://www.japantimes.co.jp/news/2022/11/30/business/eisai%2Dbiogen%2Dalzheimer%2Ddrug/<script>window.location.href = 'mailto:?subject=eisai alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge&body=https://www.japantimes.co.jp/news/2022/11/30/business/eisai%2Dbiogen%2Dalzheimer%2Ddrug/';setTimeout(function(){window.location.href= 'https://www.japantimes.co.jp/news/2022/11/30/business/eisai%2Dbiogen%2Dalzheimer%2Ddrug/'},500);</script>